BRPI0608367A2 - composição para redução de exsudação de proteìnas de soro - Google Patents

composição para redução de exsudação de proteìnas de soro

Info

Publication number
BRPI0608367A2
BRPI0608367A2 BRPI0608367-6A BRPI0608367A BRPI0608367A2 BR PI0608367 A2 BRPI0608367 A2 BR PI0608367A2 BR PI0608367 A BRPI0608367 A BR PI0608367A BR PI0608367 A2 BRPI0608367 A2 BR PI0608367A2
Authority
BR
Brazil
Prior art keywords
composition
whey protein
reducing
protein exudation
exudation
Prior art date
Application number
BRPI0608367-6A
Other languages
English (en)
Inventor
Seong-Hyun Choi
Original Assignee
Seong-Hyun Choi
Kt & G Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seong-Hyun Choi, Kt & G Corp filed Critical Seong-Hyun Choi
Publication of BRPI0608367A2 publication Critical patent/BRPI0608367A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A44—HABERDASHERY; JEWELLERY
    • A44C—PERSONAL ADORNMENTS, e.g. JEWELLERY; COINS
    • A44C15/00—Other forms of jewellery
    • A44C15/0045—Jewellery specially adapted to be worn on a specific part of the body not fully provided for in groups A44C1/00 - A44C9/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A44—HABERDASHERY; JEWELLERY
    • A44C—PERSONAL ADORNMENTS, e.g. JEWELLERY; COINS
    • A44C25/00—Miscellaneous fancy ware for personal wear, e.g. pendants, crosses, crucifixes, charms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

COMPOSIçãO PARA REDUçãO DE EXSUDAçãO DE PROTEìNAS DE SORO. é mostrada uma composição para redução de exsudação das proteínas de soro. Mais especificamente, a composição da presente invenção refere-se a uma composição capaz de aperfeiçoar condições tais como dermatite atópica, eczema atópico, prurito de pele, nasite atópica, eritema atópico ou eritroderma, dermatite de contato, asma, doença pulmonar obstrutiva crónica, etc., através de redução de exsudação das proteínas de soro em pele e mucosa.
BRPI0608367-6A 2005-02-28 2006-02-23 composição para redução de exsudação de proteìnas de soro BRPI0608367A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020050016567A KR100891595B1 (ko) 2005-02-28 2005-02-28 혈액 단백질의 삼출을 감소시키는 조성물
PCT/KR2006/000638 WO2006091033A1 (en) 2005-02-28 2006-02-23 Composition for reducing the exudation of serum proteins

Publications (1)

Publication Number Publication Date
BRPI0608367A2 true BRPI0608367A2 (pt) 2009-12-29

Family

ID=36927638

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0608367-6A BRPI0608367A2 (pt) 2005-02-28 2006-02-23 composição para redução de exsudação de proteìnas de soro

Country Status (13)

Country Link
US (1) US8853195B2 (pt)
EP (2) EP1855692B1 (pt)
JP (2) JP5074929B2 (pt)
KR (1) KR100891595B1 (pt)
CN (1) CN101155589B (pt)
AT (1) ATE533495T1 (pt)
AU (1) AU2006217261B8 (pt)
BR (1) BRPI0608367A2 (pt)
CA (1) CA2599315C (pt)
ES (1) ES2377137T3 (pt)
PL (1) PL1855692T3 (pt)
RU (1) RU2403047C2 (pt)
WO (1) WO2006091033A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100891595B1 (ko) 2005-02-28 2009-04-03 주식회사 케이티앤지 혈액 단백질의 삼출을 감소시키는 조성물
WO2007142510A1 (en) * 2006-06-09 2007-12-13 Erasmus University Medical Center Rotterdam Modulation of the immune system by inositol phospholipids
KR101277630B1 (ko) * 2010-05-19 2013-06-21 주식회사 바이오피드 탈모방지 또는 육모 촉진용 조성물
KR101200392B1 (ko) 2010-07-12 2012-11-13 주식회사 바이오피드 혈액 단백질 삼출을 동반하는 피부질환들의 치료 및 증상완화용 패치
CN103483425B (zh) * 2013-08-23 2015-03-18 南京中医药大学 一种具有致痒作用的芋蛋白提取物及其制备方法和应用
WO2019009628A2 (ko) * 2017-07-07 2019-01-10 주식회사 리포바이오랩 화상 및 욕창의 완화 및 치료용 조성물
RU2691648C1 (ru) * 2018-05-28 2019-06-17 Олег Александрович Розенберг Способ получения сурфактанта из легких крупного рогатого скота

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS624215A (ja) 1985-07-01 1987-01-10 Shiseido Co Ltd 化粧料
JPH07116010B2 (ja) 1986-03-10 1995-12-13 株式会社コーセー 化粧料
JP3298867B2 (ja) 1988-06-20 2002-07-08 株式会社資生堂 透明組成物
DE69131163T2 (de) 1990-05-18 1999-12-23 Tokyo Tanabe Co., Ltd. Asthma heilmittel
DE4434629C1 (de) 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
DE69624137T2 (de) 1995-07-27 2003-06-18 Chisso Corp., Osaka Organosiliciumverbindungen, flüssigkristallzusammensetzungen und flüssigkristallanzeigeelemente
US5698537A (en) * 1996-06-18 1997-12-16 Clarion Pharmaceuticals Inc. Method of lowering the viscosity of mucus
CA2277801C (en) 1997-01-16 2002-10-15 Massachusetts Institute Of Technology Preparation of particles for inhalation
US20040228910A1 (en) * 1997-02-11 2004-11-18 Mse Pharmazeutika Gmbh Transdermal, oral and intravenous formulations of 2, 3-dimethoxy-5-methyl-6-decaprenyl-1, 4-benzoquinone
EP1007018B1 (de) * 1997-02-12 2003-10-08 MSE Pharmazeutika GmbH Verwendung von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon inder behandlung von tinnitus
JP3783385B2 (ja) 1997-08-26 2006-06-07 キユーピー株式会社 リポソーム分散液の製造方法及びそれを用いた化粧料
AU1251999A (en) * 1997-12-03 1999-06-16 Britannia Pharmaceuticals Limited Improvements in medicaments for asthma treatment
US6320017B1 (en) * 1997-12-23 2001-11-20 Inex Pharmaceuticals Corp. Polyamide oligomers
US5989577A (en) 1998-03-02 1999-11-23 Children's Hospital Medical Center Nontoxic vernix compositions and method of producing
GB9912639D0 (en) * 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
WO2000030654A1 (en) 1998-11-26 2000-06-02 Britannia Pharmaceuticals Limited Anti-asthmatic combinations comprising surface active phospholipids
AU6083899A (en) 1999-09-16 2001-04-17 Aventis Behring Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
WO2001085136A2 (en) * 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
WO2002017878A1 (en) * 2000-09-01 2002-03-07 Marcus Larsson Lung surfactant compositions with dynamic swelling behaviour
RU2198670C1 (ru) 2002-02-19 2003-02-20 ООО "Биосурф" Способ получения сурфактанта из легких крупного рогатого скота
US20040009216A1 (en) * 2002-04-05 2004-01-15 Rodrigueza Wendi V. Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
JP2004131401A (ja) 2002-10-09 2004-04-30 Rohto Pharmaceut Co Ltd 皮膚化粧料
JP2004231544A (ja) 2003-01-29 2004-08-19 Nikko Chemical Co Ltd リン脂質のメラニン生成抑制剤としての利用
JP2004352643A (ja) 2003-05-29 2004-12-16 Kose Corp ゲル状化粧料
WO2004110450A1 (en) 2003-06-16 2004-12-23 Altana Pharma Ag Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
TW200507879A (en) 2003-07-10 2005-03-01 Kose Corp Powdery compositions and skin preparation containing the same for external use
CN1560057A (zh) 2004-03-10 2005-01-05 山东师范大学 高纯度磷脂酰肌醇的制备方法
KR100891595B1 (ko) 2005-02-28 2009-04-03 주식회사 케이티앤지 혈액 단백질의 삼출을 감소시키는 조성물

Also Published As

Publication number Publication date
HK1112592A1 (en) 2008-09-12
CA2599315C (en) 2013-01-22
KR100891595B1 (ko) 2009-04-03
CN101155589B (zh) 2011-06-15
AU2006217261B8 (en) 2010-01-28
CN101155589A (zh) 2008-04-02
WO2006091033A1 (en) 2006-08-31
US20090029950A1 (en) 2009-01-29
AU2006217261B2 (en) 2009-10-01
JP2008531682A (ja) 2008-08-14
ATE533495T1 (de) 2011-12-15
RU2007135881A (ru) 2009-04-10
EP2295025A1 (en) 2011-03-16
ES2377137T3 (es) 2012-03-22
US8853195B2 (en) 2014-10-07
EP1855692A1 (en) 2007-11-21
AU2006217261A1 (en) 2006-08-31
KR20060095141A (ko) 2006-08-31
JP2012188434A (ja) 2012-10-04
RU2403047C2 (ru) 2010-11-10
EP1855692B1 (en) 2011-11-16
JP5074929B2 (ja) 2012-11-14
PL1855692T3 (pl) 2012-05-31
CA2599315A1 (en) 2006-08-31
EP1855692A4 (en) 2008-09-10

Similar Documents

Publication Publication Date Title
ATE417610T1 (de) Zusammensetzung enthaltend 6-ä3-(1-adamantyl)-4- methoxyphenylü-2-naphthanoesäure zur behandlung dermatologischer erkrankungen
GT200600316A (es) Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida.
CL2013001673A1 (es) Composicion acuosa que comprende aproximadamente 18% p/v de concentracion, donde al menos el 95% de las proteinas son igg; metodo mejorado para preparar dicha composición.
BRPI0514340A (pt) formulações de estabilização
CR9528A (es) Inhibitors of microsomal triglyceride transfer protein and apo-b secretion
ATE524741T1 (de) Zusammensetzungen und verwendungen zur stabilisierung von transthyretin und zur hemmung von transthyretin-fehlfaltung
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
CR11031A (es) Composiciones de enzima digestiva estable
DK1641352T3 (da) Sammensætninger til forbedret oxidativ status hos katte
MX2018005512A (es) Agentes de union de esclerostina.
BRPI0910821A8 (pt) Método para modificar uma proteína, alimento, preparação de enzima para modificar uma proteína, e, método para estabelecer uma relação ótima de proteína glutaminase para transglutaminase
WO2006117217A3 (de) Neue verwendung von spiegelmeren
EA200501675A1 (ru) Фармацевтическая композиция, содержащая лактат, и ее применение
EA201070187A1 (ru) Модифицированные ферменты лецитин-холестерин ацилтрансферазы
ATE547009T1 (de) Zusammensetzungen und verfahren zur förderung von körperfettverlust
DE602006003760D1 (de) Zungen
MX373170B (es) Variantes de la familia il-1.
BRPI0608367A2 (pt) composição para redução de exsudação de proteìnas de soro
BRPI0519070A2 (pt) composiÇço de fator de crescimento de queratinàcito liofilizada, mÉtodos para preparar um fator de crescimento de queratinàcito liofilizado, e para tratar uma doenÇa, e, kit para preparar uma composiÇço farmacÊutica aquosa
WO2007134118A3 (en) Protein based composition and methods of using same
EP2197493A4 (en) MICROENCAPSULATED LIPOSOMAL COMPOSITIONS
ATE358992T1 (de) Enteralpräparat zur vorbeugung gegen bzw. behandlung von sepsis
WO2006079057A3 (en) Methods and compositions for specific inhibition of protein splicing by small molecules
ATE526344T1 (de) Nahrungsmittel zur förderung der differenzierung von osteoblasten und zur inhibierung der differenzierung von osteoclasten

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2502 DE 18-12-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI